Pathway Genomics

Pathway Genomics is a CAP accredited global clinical lab offering genetic tests for cancer risk, drug responses, and other conditions.

Pathway Genomics provides a comprehensive set of genomic testing services across the healthcare spectrum, including tests for general health and wellness, liquid biopsy, pharmacogenomics, hereditary cancer risk and carrier screening. 

Pathway Genomics Corporation was incorporated in 2008 and is based in San Diego, California.

Pathway Genomics’ testing services cover a variety of conditions including cancer risk, cardiac health, inherited diseases, nutrition and exercise response, as well as drug response for specific medications including those used in pain management and mental health.

Pathway Genomics offers test services in the areas of liquid biopsy, hereditary cancer, general health and wellness, pharmacogenomics, and carrier screening, as well as corporate wellness services.

Pathway Genomics's testing services cover various conditions, including cancer risk, cardiac health, inherited diseases, and nutrition and exercise response, as well as drug response for specific medications that are used in pain management and mental health. 

Pathway Genomics Corporation has strategic partnerships with Standard Process and Rainbow Genomics.

 

Pathway Genomics is backed by IBM Watson & IBM Ventures.

 

 

  • Year founded: 2008
  • Funding Info: $43M in 5 Funding Rounds (Last Funding Type: Series E)
  • Yearly Revenue: $10M-$20M (2018)
  • Employee Size: 51-200
  • Business Valuation: NA
  • City/Town: San Diego
  • State: California
  • Country: United States
Related businesses